Quantitative Subanalysis of Optical Coherence Tomography after Treatment with Ranibizumab for Neovascular Age-Related Macular Degeneration
Investigative Ophthalmology & Visual Science2008Vol. 49(7), pp. 3115–3115
Citations Over TimeTop 10% of 2008 papers
Pearse A. Keane, Sandra Liakopoulos, Sharel Ongchin, Florian M. Heussen, Sandeep Msutta, Karen T. Chang, Alexander C. Walsh, Srinivas R. Sadda
Abstract
Although neurosensory retinal edema and SRF showed an early reduction to nadir after the initiation of ranibizumab therapy, the effect on the retina was attenuated over time, suggesting possible tachyphylaxis. PED volume showed a slower but progressive reduction. Manual quantitative OCT subanalysis may allow a more precise understanding of anatomic outcomes and their correlation with visual acuity.
Related Papers
- → Ranibizumab for Neovascular Age-Related Macular Degeneration(2006)5,818 cited
- → Estimated Cases of Blindness and Visual Impairment from Neovascular Age-Related Macular Degeneration Avoided in Australia by Ranibizumab Treatment(2014)50 cited
- → Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration(2015)25 cited
- → Pharmacogenetics of the Treatment Response of Age-Related Macular Degeneration with Ranibizumab and Bevacizumab(2013)13 cited
- → Neovascular Age-Related Macular Degeneration(2013)11 cited